Mucosal melanoma: pathogenesis, clinical behavior, and management (Q38015774)

27 August 2017

title

Mucosal melanoma: pathogenesis, clinical behavior, and management (English)

1 reference

27 August 2017

0 references

1 reference

Michael A Postow

1

1 reference

27 August 2017

Omid Hamid

series ordinal

2

1 reference

27 August 2017

Richard D Carvajal

series ordinal

3

1 reference

27 August 2017

publication date

1 October 2012

1 reference

27 August 2017

published in

Current Oncology Reports

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

441-448

1 reference

Incidence of noncutaneous melanomas in the U.S.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

21 January 2018

Primary mucosal melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Mucosal melanoma of the female genital tract is a multifocal disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Sentinel lymph node biopsy: A new perspective in head and neck mucosal melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Sentinel-node biopsy or nodal observation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Postoperative radiotherapy for primary mucosal melanoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

The role of abdominoperineal resection as surgical therapy for anorectal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Vulvar melanoma: a multivariable analysis of 644 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Primary malignant melanoma of the vagina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Vulvar melanoma: is there a role for sentinel lymph node biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Primary malignant melanoma of the gall bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Malignant melanoma of the oesophagus: clinicopathological features, lack of p53 expression and steroid receptors and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Melanoma of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Biochemotherapy in patients with advanced head and neck mucosal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Biochemotherapy in patients with metastatic anorectal mucosal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Determinants of BRAF mutations in primary melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Major response to imatinib mesylate in KIT-mutated melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

KIT as a therapeutic target in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Sunitinib therapy for melanoma patients with KIT mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Major response to everolimus in melanoma with acquired imatinib resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0244-X

Radiotherapy after surgical resection for head and neck mucosal melanoma.

21 January 2018

1 reference

12 December 2020

Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma

1 reference

12 December 2020

Adjuvant therapy of melanoma

1 reference

12 December 2020

[Primary malignant melanoma of the gallbladder. Case report and literature review]

1 reference

12 December 2020

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

1 reference

12 December 2020

Management of vulvar melanoma and review of the literature.

1 reference

12 December 2020

Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system

1 reference

12 December 2020

Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits

1 reference

12 December 2020

Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy

1 reference

12 December 2020

Primary mucosal malignant melanoma of the head and neck

1 reference

12 December 2020

Mucosal melanoma of the head and neck

1 reference

12 December 2020

Primary malignant melanoma of the vagina: case report and review of literature.

1 reference

12 December 2020

Primary malignant melanoma of the male urethra

1 reference

12 December 2020

Primary malignant melanoma of the oral cavity in Japan. With special reference to mucosal melanosis

1 reference

12 December 2020

Mucosal melanoma of the head and neck

1 reference

12 December 2020

Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors

1 reference

12 December 2020

Melanoma in the gastrointestinal tract

1 reference

12 December 2020

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features

1 reference

12 December 2020

Surgical management of primary anorectal melanoma

1 reference

12 December 2020

Malignant melanoma of the skin of the head and neck. An analysis of 405 cases

1 reference

12 December 2020

10.1007/S11912-012-0244-X

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1010407702

0 references

1 reference